tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Penumbra raises FY25 revenue view to $1.355B-$1.370B from $1.34B-$1.36B

Consensus is for FY25 revenue $1.35B. The Company maintains guidance for U.S. Thrombectomy growth of 20% to 21% compared to 2024 levels. The Company also maintains guidance for both gross margin and operating margin for FY25.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1